Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, announced terms for its IPO on Thursday.
The Boca Raton, FL-based company plans to raise $20 million by offering 1.8 million shares at a price range of $10 to $12. At the midpoint of the proposed range, Sensus Healthcare would command a fully diluted market value of $95 million.
Sensus Healthcare was founded in 2010 and booked $10 million in sales for the 12 months ended December 31, 2015. It plans to list on the Nasdaq under the symbol SRTSU. Joseph Gunnar & Co. and Feltl and Company are the joint bookrunners on the deal. It is expected to price during the week of March 28, 2016.
